Who Owns MapLight Therapeutics Stock?
NASDAQ: MPLTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 58.64%
- Institutions (% of float)
- 122.66%
- Held by insiders
- 52.19%
- Institutional holders
- 141
- Institutions 47.8%
- Insiders 52.2%
- Public and other 0.0%
Who owns MapLight Therapeutics stock?
Institutional investors own about 58.6% of MapLight Therapeutics's shares, spread across 141 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 52.19% of MPLT.
The largest institutional holders are FCPM III Services B.V. (7.97%), Goldman Sachs Group Inc (6.48%) and Nan Fung Group Holdings Limited (4.14%). Together, the top 10 institutions control 36.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their MPLT positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MPLT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FCPM III Services B.V. | 4.43M | 7.97% | +37.3% |
| Goldman Sachs Group Inc | 3.60M | 6.48% | +84.8% |
| Nan Fung Group Holdings Limited | 2.30M | 4.14% | +136.8% |
| Novo Holdings A/S | 2.09M | 3.75% | -43.4% |
| Blackrock Inc. | 1.71M | 3.08% | +67.1% |
| FMR, LLC | 1.54M | 2.77% | +87.2% |
| Deep Track Capital, Lp | 1.32M | 2.37% | +100.0% |
| Baker Bros. Advisors, LP | 1.17M | 2.10% | +219.9% |
| Price (T.Rowe) Associates Inc | 1.13M | 2.04% | -20.4% |
| T. Rowe Price Investment Management, Inc. | 945.22K | 1.70% | -66.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MPLT
| Fund | Shares | % Held |
|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. | 625.05K | 1.12% |
| T. Rowe Price Small-Cap Value Fund, Inc. | 605.60K | 1.09% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 552.28K | 0.99% |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Value Equity Trust | 411.66K | 0.74% |
| SmallCap World Fund Inc | 404.39K | 0.73% |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 402.79K | 0.72% |
| T. Rowe Price New Horizons Fund, Inc. | 398.81K | 0.72% |
| T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd. | 342.34K | 0.62% |
| iShares Trust-iShares Russell 2000 ETF | 322.94K | 0.58% |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Core Equity Trust | 293.79K | 0.53% |
Frequently asked questions
Who is the largest shareholder of MapLight Therapeutics?
FCPM III Services B.V. is the largest institutional shareholder of MPLT, owning 7.97% of shares outstanding (4.43M shares) as of its latest 13F filing.
What percentage of MapLight Therapeutics is owned by institutions?
Institutions own about 58.6% of MPLT shares and 122.7% of the public float.
How much of MapLight Therapeutics do insiders own?
Insiders, such as officers and directors, own about 52.19% of MPLT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.